Advertisement

Topics

Janssen’s RA drug sirukumab fails to get FDA Advisory Committee nod

05:59 EDT 4 Aug 2017 | Pharmaceutical Business Review

Janssen Biotech has received a setback for its rheumatoid arthritis (RA) drug sirukumab after the Arthritis Advisory Committee of the US Food and Drug Administration (FDA) decided not to recommend its approval.

Original Article: Janssen’s RA drug sirukumab fails to get FDA Advisory Committee nod

NEXT ARTICLE

More From BioPortfolio on "Janssen’s RA drug sirukumab fails to get FDA Advisory Committee nod"

Quick Search
Advertisement
 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...